The following excerpt is from the company's SEC filing.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if
other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by item 25(b)
per Exchange Act Rules 14a-6(i)(1) and 0-11.
Your Vote Counts!
50 HAMPSHIRE STREET
CAMBRIDGE, MA 02139
2022 Annual Meeting
Vote by September 29, 2022
11:59 PM ET
You invested in EQRX, INC. and it’s time to vote!
Y ou have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the
availability of proxy material for the stockholder meeting to be held on September 30, 2022.
Vote Virtually at the Meeting*
September 30, 2022
8:00 AM EDT
*Please check the meeting materials for any special requirements for meeting attendance.
Point your camera here and
vote without entering a
For complete information and to vote, visit www.ProxyVote.com
Get informed before you vote
View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by
requesting prior to September 16, 2022. If you would like to request a copy of the material(s) for this and/or future stockholder
meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to firstname.lastname@example.org.
If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not
otherwise receive a paper or email copy.
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the
upcoming stockholder meeting. Please follow the instructions on
the reverse side to vote these important matters.
Vote at www.ProxyVote.com
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.
1. Election of three class I directors to serve until the 2025 annual meeting of stockholders.
1c. Sandra Horning
1a. Paul Berns
2. Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year
ending December 31, 2022.
1b. Jorge Conde
NOTE: Such other business as may properly come before the meeting or any adjournment or postponement thereof.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever CM Life Sciences III Inc. makes a similar move, sign up!